SCHEMBL8288353

SCHEMBL8288353

CCOC(=O)c1c(-c2ccc(C(F)(F)F)cc2)c(C#N)c(SC)n1C

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 11/20 0.59
GRIA2 P42262 10/20 0.59
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CRHBP P24387 1/20 0.40
KMT2A Q03164 1/20 0.40
CRHR2 Q13324 1/20 0.40
FNTA P49354 2/20 0.39
FNTB P49356 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 1/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8289367 0.91 GRIA4 (0.72) GRIA4GRIA2ALDH1A1L3MBTL1FNTA
SCHEMBL4378785 0.86 GRIA4 (0.73) GRIA4GRIA2ALDH1A1L3MBTL1NPSR1
SCHEMBL8289366 0.85 GRIA4 (0.56) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL8289353 0.85 GRIA4 (0.58) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL13611799 0.85 GRIA4 (0.80) GRIA4GRIA2
SCHEMBL8288358 0.84 GRIA4 (0.55) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL8289337 0.83 GRIA4 (0.53) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL8288359 0.82 GRIA4 (0.58) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL8289343 0.82 GRIA4 (0.54) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E
SCHEMBL8289344 0.81 GRIA4 (0.49) GRIA4GRIA2ALDH1A1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625932-B2 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY (US) 2009-12-01 US disclosed
EP-1670757-B1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS LILLY CO ELI (US) 2009-05-06 EP disclosed
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY 2007-03-22 US disclosed
WO-2005040110-A1 PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors GRIN1, GRIN3A, GRIK5 GRIA4 16/4885GRIA2 17/4885ALDH1A1 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.